[1]
C.-Y. Wang, E. . Schapkaitz, S. . Louw, and B. Jacobson, “Thrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID‑19 pandemic”, samj, vol. 115, no. 9, pp. 39–45, Nov. 2025.